top of page

The

System

Novel technology to continuously monitor a mother’s risk for postpartum hemorrhage (PPH) during Labor and Delivery.

Reducing Time to Treatment

We improve risk prediction up to 10x beyond the current standard of care

Vasowatch conducted an observational study on a diverse population of 525 women in Labor and Delivery at a large urban Pennsylvania Hospital.  We compared the hospital's expert-based survey risk assessment administered at admission to that of the Vasowatch algorithm.  Here are the results:

Competitive Landscape

Frame 67.png

Improved risk prediction enables timely & cost saving treatment

Dose of a uterotonic medication

$10-$500

Blood transfusion

>$3000

Vasowatch System 1.0

Completed 07/24

Frame 344.png

Sibel Health sensors
510(K)

SaMD
De Novo

Dashboards
Bedside + Nurses’ Station

bottom of page